Posted:
10/25/2024, 11:16:01 AM
Location(s):
Redwood City, California, United States ⋅ California, United States
Experience Level(s):
Senior
Field(s):
Business & Strategy
Who We Are
Arcellx is a public, clinical-stage biotechnology company reimagining cell therapy by engineering innovative immunotherapies for patients with cancer and other incurable diseases. We believe that cell therapies are one of the forward pillars of medicine and our mission is to destroy cancer and advance humanity by developing cell therapies that are safer, more effective, and more broadly accessible.
Our team members are made up of talented innovators and dreamers working from our offices in Rockville, Maryland, and Redwood City, California. At Arcellx, we hire exceptional people and create a fun, diverse, supportive, and informal environment that allows everyone to do their best work.
What Matters to Us
Living our core values is essential to maintaining a work environment that is high-performing, inclusive, and collaborative. We look for candidates who demonstrate strong values alignment and bring different backgrounds, viewpoints, and abilities to the team.
Arcellx Core Values
How You’ll Make a Difference
In this role, you’ll use your expertise in crafting and delivering drug development strategies to manage pipeline projects from clinical candidate nomination through clinical proof of concept, including assessing ongoing project viability, management and oversight of key preclinical data updates, and readiness for IND preparation and filings.
This role has broad impact across the organization, working with cross-functional stakeholders, including senior management, to ensure alignment, timely decision making, and escalation of project challenges, ultimately maximizing the likelihood of clinical and commercial success.
The “Fine Print” – What You’ll Do
Skills and Experience We Look For
#LI-Onsite
Website: https://www.arcellx.com/
Headquarter Location: Gaithersburg, Maryland, United States
Employee Count: 51-100
Year Founded: 2015
IPO Status: Public
Last Funding Type: Post-IPO Equity
Industries: Biopharma ⋅ Biotechnology ⋅ Health Care ⋅ Life Science ⋅ Pharmaceutical